Mycophenolic acid, an inhibitor of purine metabolism, was shown to block the replication of vaccinia virus in normal cell lines. This observation led to the development of a dominant one-step plaque selection system, based on expression of the Escherichia coli gpt gene, for the isolation of recombinant vaccinia viruses. Synthesis of xanthine-guanine phosphoribosyltransferase enabled only the recombinant viruses to form large plaques in a selective medium containing mycophenolic acid, xanthine, and hypoxanthine. To utilize the selection system efficiently, we constructed a series of plasmids that contain the E. coli gpt gene and allow insertion of foreign genes into multiple unique restriction endonuclease sites in all three reading frames between the translation initiation codon of a strong late promoter and synthetic translation termination sequences. The selectionexpression cassette is flanked by vaccinia virus DNA that directs homologous recombination into the virus genome. The new vectors allow high-level expression of complete or partial openi reading frames and rapid construction of recombinant viruses by facilitating the cloning steps and by simplifying their isolation. The system was tested by cloning the E. coli I8-galactosidase gene; in 24 h, this enzyme accounted for approximately 3.5% of the total infected-cell protein.
Mycophenolic acid, an inhibitor of purine metabolism, was shown to block the replication of vaccinia virus in normal cell lines. This observation led to the development of a dominant one-step plaque selection system, based on expression of the Escherichia coli gpt gene, for the isolation of recombinant vaccinia viruses. Synthesis of xanthine-guanine phosphoribosyltransferase enabled only the recombinant viruses to form large plaques in a selective medium containing mycophenolic acid, xanthine, and hypoxanthine. To utilize the selection system efficiently, we constructed a series of plasmids that contain the E. coli gpt gene and allow insertion of foreign genes into multiple unique restriction endonuclease sites in all three reading frames between the translation initiation codon of a strong late promoter and synthetic translation termination sequences. The selectionexpression cassette is flanked by vaccinia virus DNA that directs homologous recombination into the virus genome. The new vectors allow high-level expression of complete or partial openi reading frames and rapid construction of recombinant viruses by facilitating the cloning steps and by simplifying their isolation. The system was tested by cloning the E. coli I8-galactosidase gene; in 24 h, this enzyme accounted for approximately 3 .5% of the total infected-cell protein.
Vaccinia virus is a useful vector for gene expression in mammalian cells (for recent reviews, see references 12, 14, and 18). Advantages include the maintenance of infectivity, wide host range, large DNA capacity, and correct synthesis, processing, and transport of proteins. Because transcription of vaccinia virus genes is carried out by virus-encoded enzymes in the cytoplasm and splicing of RNA does not occur, there are requirements for vaccinia virus promoters and uninterrupted open reading frames. In addition, the large size and lack of infectivity of the vaccinia virus genome prohibit the construction of recombinants by standard in vitro cloning techniques. A two-step procedure has been developed to overcome these difficulties. In the first step, a plasmid is constructed that contains a foreign gene(s) controlled by a vaccinia virus promoter(s) and flanked by sequences derived from a nonessential site on the viral genome. In the second step, the foreign genetic material in the plasmid vector is inserted into the viral genome by homologous recombination in vivo.
There are several areas in which fundamental improvements in vaccinia virus vectors can be made. These relate to methods of recombinant virus selection, optional use of incomplete open reading frames, and levels of foreign gene expression. Recombinant vaccinia viruses have been identified primarily by plaque hybridization (20) , thymidine kinase (tk)-negative selection (13), or p-galactosidase expression (5, 21) . Of these, only insertional inactivation of the tk gene is a true selection step. Disadvantages of this method, however, include requirements for (i) inactivation of the viral tk gene which attenuates virus infectivity (4), (ii) use of special TKcell lines, and (iii) use of mutagenic selective agents, e.g., 5-bromodeoxyuridine. In addition, spontaneous tk mutants arise at a high frequency, necessitating additional steps to distinguish them from recombinants. Potential methods of using the neomycin resistance gene as a dominant selectable marker for isolating recombinant vaccinia viruses containing foreign genes of interest were suggested by Franke et al. (7) . In this communication, we show that mycophenolic acid (MPA), an inhibitor of purine metabolism, reversibly blocks formation of vaccinia virus plaques on a variety of cell lines. This inhibition was overcome by incorporating the Escherichia coli gpt gene into vaccinia virus and adding xanthine and hypoxanthine to the medium. Using this information, we constructed a series of new vectors in which coexpression of the gpt gene provides efficient dominant selection of recombinants and overcomes all of the deficiencies of TK-selection. At the same time, we incorporated into these vectors a strong late promoter that provides high levels of expression, translation initiation and termination codons, and multiple restriction sites in three different frames which permit expression of partial or complete foreign genes. , and 10-5) of the trypsinized virus stock were used to infect the BSCI cells. After 1.5 h of incubation at 37°C, the cells were overlaid with the gpt-selective medium containing 1% of low-melting-point agarose. After 2 days of incubation, the cells were stained with neutral red (GIBCO Laboratories). The plaques were readily visible after overnight incubation.
MATERIALS
Preparation and analysis of DNA. Recombinant plasmids were constructed and isolated as described (16) . For the genomic analysis of recombinant viruses, 2.5 x 106 BSCI cells were infected with the material obtained from a single plaque and grown for 24 h in selective medium. Total cellular DNA was extracted (10), digested with Hindlll, electrophoresed through a 1% agarose gel, and subjected to Southern blot analysis (16) .
Construction of recombinant plasmids. (i) pTK61-gpt. HindIII linkers were added to the HindIII-HpaI fragment of the E. coli gpt gene obtained from plasmid pSV2-gpt (19) . Subsequently, the fragment was inserted into the unique HindIII site of pGS61 (14) , resulting in the plasmid pTK61-gpt.
(ii) pPll. The HindIII and SstI sites, flanking the promoter from the gene encoding the 11-kilodalton polypeptide (the 11K polypeptide) in plasmid pSC42, were converted into XhoI site by T4 polymerase treatment and ligation of XhoI linkers. The plasmid pSC42 has the ClaI-EcoRI fragment containing the promoter from the gene encoding the 11K polypeptide (1) cloned into the SphI site of pUC19 (S. Chakrabarti, unpublished data).
(iii) pTKgpt-Fls and pTKgpt-oFls. For details of the construction of pTKgpt-Fls and pTKgpt-oFls, see Fig. 3 .
(iv) pTKgpt-F2s and pTKgpt-F3s. The frameshift mutations were produced by oligonucleotide-directed mutagenesis (15) . To obtain pTKgpt-F2s, we used a 30-mer oligonucleotide (5'-GACCTGCAGGAATTCCATTTATAGCATAG A-3'), and to obtain pTKgpt-F3s, we used another 30-mer (5'-ACCTGCAGGAATTCCCATTTATAGCATAGA-3').
The mutants were screened by plasmid sequencing (11) with the help of a 20-mer primer (5'-GCGATGCTACGCTAGT CACA-3') derived from the upstream region of the promoter from the gene encoding the 11K polypeptide (nucleotides -96 to -76 upstream of the initiation codon). The primary structures around the promoter region of the gene encoding the 11K polypeptide and the unique cloning sites in all vectors were confirmed by plasmid sequencing.
(v) pTKgpt-Fls, and pTKgpt-oFlsp. The BamHI fragment of pMC1871 (26) (19) . Treatment of host cells with MPA should therefore severely inhibit the growth of viruses. To prove this assumption, we assayed the effect of increasing amounts of MPA on plaque formation by vaccinia virus. We found that 25 ,ug of MPA per ml of medium resulted in a nearly complete inhibition of plaque formation in all cell lines tested so far (BSCI, CVI, and human TK-143 cells). In BSCI and CVI cells, only a few tiny plaques could be observed on crystal violet-stained monolayers after 2 days of incubation (Fig.  1A) . Replacement of the selective medium with normal medium resulted in plaque formation comparable to that of the control (Fig. 1B) , indicating that the inhibition is reversible.
Plaque formation in the presence of MPA owing to E. coli gpt expression. The inhibition of the de novo synthesis of purines by MPA can be overcome by a cell that expresses the E. coli gpt gene, which codes for the enzyme xanthineguanine phosphoribosyltransferase (XGPRT), in the presence of xanthine and hypoxanthine in the growth medium (19) . To determine whether the block of purine synthesis by MPA can also be overcome by a recombinant virus expressing the bacterial XGPRT, we first constructed the plasmid pTK61-gpt. In this construct, the gpt gene is cc the promoter from the vaccinia virus gene encodi polypeptide and is flanked by viral tk sequences promoter was chosen because it is active early infection (6) and might provide continuous produ bacterial purine salvage enzyme. The plasmid w ted into CVI cells that were infected with wild-t that the gpt gene would be recombined into the vi Putative recombinants were detected by a plaqi BSCI cells in the presence of MPA, xanthine, an thine. Large plaques formed only when the gp used for transfection, suggesting that the desire nants behaved in the anticipated manner. One of binants was plaque purified twice under selective and a small virus stock was grown. A plaque as strated that this recombinant, in contrast to th virus, formed plaques on BSCI cells in the r selective medium (Fig. 1C) .
The genomic analysis of virus grown from si picked plaques that formed during the first selec shown in Fig. 2 . The HindIII fragments of all s contain the anticipated 2.0-kilobase-pair (kbp) fr; hybridizes with the gpt probe ( Fig. 2A) . After DNA was washed off, the same Southern filter X ized to a vaccinia virus tk gene-specific probe (Fi tk sequences can be detected as a large fragmei and a small one (1.0 kbp), indicating the integrn gpt gene into the viral tk locus. Since all plaques I the first selection step have integrated the select no other screening procedures are necessary t( viral recombinant.
Construction of the insertion and expressi pTKgpt-Fls, pTKgpt-F2s, and pTKgpt-F3s. We a series of plasmids that use the gpt gene as marker and that allow the expression of for controlled by the promoter of the major late 11K I (Fig. 3) . The 5' regulatory region of the gene et ilK polypeptide lies within a 30-kbp segment loc diately upstream of the ATG initiation codon (1 the initiation codon forms part of a highly TAAATG sequence within which the 5' ends of 1 map (1, 24), we chose not to alter this region. Th presence of an EcoRI site immediately downstr ATG facilitated the insertion of a polylinker wi unique cloning sites. Three vectors in which guanosine residues follow the ATG allow any A 1 2 3 4 5 6 7 quences to be inserted in the correct reading frame. These vectors also provide all-frame stop codons at the end of the polylinker. The sequences downstream of the initiation codon of the gene encoding the 11K polypeptide for the three vectors (termed pTKgpt-Fls, pTKgpt-F2s, and pTKgpt-F3s) are shown in Fig. 4 . The vector pTKgpt-oFls (Fig. 3) virus-infected cells is more than 3% of the total cellular protein, an amount that should be easily detectable in a Coomassie blue-stained gel. In fact, a strong band in the 100,000-kilodalton range was observed upon electrophoresis of proteins from cells infected with a pTKgpt-Fls-based virus, and not in the proteins of wild-type virus-infected cells (data not shown). The level of P-galactosidase expression with the promoter of the gene encoding the l1K polypeptide was about twofold higher than that achieved with the hybrid vaccinia virus-T7 RNA polymerase system under the infection conditions described in Fig. 5 .
DISCUSSION
Selection for animal cells that express the E. coli gene coding for XGPRT was originally described by Mulligan and Berg (19) and is based on the fact that the corresponding enzyme of mammalian cells cannot efficiently use xanthine for GMP synthesis when de novo purine synthesis is blocked. Cells which stably expressed the gpt gene, however, could be selectively grown in the presence of MPA and xanthine. Our initial experiments indicated that MPA inhibited vaccinia virus replication. We were unsure, however, whether this system could be adapted to a one-step virus plaque selection procedure. The first question was whether cells that had been pretreated with MPA would still be competent to support virus replication if XGPRT were made. The second question was that if MPA blocked purine metabolism, vaccinia virus might be unable to synthesize mRNA necessary to produce XGPRT. According to this notion, even a delay in addition of MPA would not help, since multiple rounds of replication in neighboring cells are required to form a visible plaque, and this problem would arise in each newly infected cell. With this in mind, we placed the gpt gene under the control of both early and late vaccinia virus transcriptional regulatory signals to have immediate and continued formation of gpt mRNA. We hoped that on adding an appropriate concentration of MPA, a small amount of mRNA would be made initially and that translation of this mRNA would permit more optimal levels of purine metabolism to resume. Apparently these conditions are met, at least for the three cell lines tested, at a concentration of 25 ,ug of MPA per ml, since wild-type virus forms no plaques or a few microsize plaques, whereas gpt-recombinants form good-size plaques that can be readily picked. It is possible that the optimal MPA concentration will vary with other cell lines. In our experience, all plaques picked at the first selection step contain recombinants. Any contaminating wild-type virus (or an accidentally picked microplaque) is removed by a second round of plaque purification in selective medium. Importantly, no background of spontaneously occurring gpt+ virus would be expected or has been observed. By comparison, spontaneous tk mutants are always a problem when using tk selection.
The gpt gene was incorporated into a plasmid vector that has a vaccinia virus promoter and unique restriction endonuclease sites for insertion of a foreign gene. Because of vaccinia virus-derived flanking sequences, the entire selection-expression cassette is inserted as a unit into the vaccinia virus genome by homologous recombination. Thus, all of the Gpt+ recombinants analyzed also contained the foreign gene that had been inserted into the plasmid vector. For our convenience, the flanking sequences used in this study were derived from the vaccinia virus tk gene; however, since tk selection is no longer required, any nonessential site in the vaccinia virus genome should be suitable. To achieve high levels of expression, the promoter chosen for the vectors was derived from the major 11K structural protein (27) . Although the mechanism of late transcription is still poorly understood and involves the attachment of a unique 5' poly(a) leader (2, 25, 28) (3) and specific P-galactosidase activity (17) were determined. The virus vF1s, was derived from the vector pTKgpt-Fls; the virus v0F1sp is a derivative of pTKgpt-oFls; and vtat was derived from pSC11 (2) . T7 refers to the viruses vTF7-3 (this virus expresses the bacteriophage T7 RNA polymerase) and vTFgal2 (a virus expressing the lacZ gene behind the T7 promoter); cells were infected with 7.5 PFU of each of the two viruses per cell. Prior to infection, the titers of all viruses were redetermined. P-Galactosidase activities are mean values of two independent experiments. even exceeded that obtained with the recent bacteriophage T7-vaccinia virus hybrid system (8) . Whether this will hold true for expression of other genes remains to be determined. The vectors described here may be suitable for direct cloning and expression of open reading frames in mammalian cells in a manner similar to that used with bacteriophage X in E. coli.
The development of additional selection methods will further enhance the versatility of vaccinia virus vectors. Franke et al. (7) demonstrated the enrichment and plaqueforming ability of recombinant vaccinia viruses that express the neomycin resistance gene when grown in the presence of the antibiotic G418 and indicated their intention of developing a coexpression vector similar to that described here for gpt.
In summary, gpt selection provides a number of important advantages over previous procedures devised to isolate recombinant vaccinia viruses. These include one-step plaque isolation without the need for enrichment, application to a variety of cell lines, use of alternative insertion sites in the vaccinia virus genome, and absence of spontaneous selectable mutants. In addition, 5-bromodeoxyuridine, which is used for tk selection, is highly mutagenic, whereas MPA acid is nonmutagenic in the Ames test and in the related SOS test (22) . Avoidance of mutagens should ensure virus stability. Finally, we would like to point out that gpt selection also might prove useful with different virus vectors, including other members of the poxvirus family, herpesviruses, adenoviruses, retroviruses, and baculoviruses.
